NEW YORK--(BUSINESS WIRE)--Bioenvision, Inc. (NasdaqGM:BIVN) a developer of oncology drugs today announced Joseph P. Cooper has joined its board of directors effective immediately. Mr. Cooper currently serves as Executive Vice President, Corporate and Product Development at Medicis Pharmaceutical Corporation (NYSE:MRX).
